Gyre Therapeutics
San Diego, US · Delaware corporation
Founders & leadership
HY
Han YingNamed on SEC filing
UN
Usman NassimNamed on SEC filing
WY
Weiguo YuNamed on SEC filing
RP
Renate ParryNamed on SEC filing
YL
Ying LuoNamed on SEC filing
SM
Songjiang MaNamed on SEC filing
TE
Thomas EastlingNamed on SEC filing
GG
Gordon G. CarmichaelNamed on SEC filing
RC
Ruoyu ChenNamed on SEC filing
CW
Charles WuNamed on SEC filing
Reported raises · per SEC filings
Form D private placements$5M disclosed across 1 round · 2023
▶$5MraisedNov 2023 · 1 investors · PharmaceuticalsRule 506(b)
▶$5MraisedNov 2023 · 1 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Han YingDirector
- Usman NassimDirector
- Weiguo YuExecutive Officer
- Renate ParryDirector
- Ying LuoDirector
- Songjiang MaDirector, Executive Officer
- Thomas EastlingDirector
- Gordon G. CarmichaelDirector
- Ruoyu ChenExecutive Officer
- Charles WuDirector, Executive Officer
- Offering amount
- $5M
- Amount sold
- $5M
- First sale
- Oct 2023
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- How much funding has Gyre Therapeutics raised?
- Gyre Therapeutics has disclosed $5M raised across 1 round.
- Where is Gyre Therapeutics headquartered?
- Gyre Therapeutics is headquartered in San Diego, US.